CN3 ONCOLOGISTS COST-EFFECTIVENESS THRESHOLDS FOR NEW CANCERTHERAPIES
Abstract
Authors
E Nadler B Eckert P Neumann
E Nadler B Eckert P Neumann
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now